CWM
NUVB icon

Cornerstone Wealth Management’s Nuvation Bio NUVB Stock Holding History

Cornerstone Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$64.4K Hold
11,342
– – ﹤0.01% 734
2026
Q1 		$48.7K Buy
11,342
+150
+1% +$836 ﹤0.01% 701
2025
Q4 		$100K Buy
+11,192
New +$69.3K 0.01% 677

Other funds holding NUVB

ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return

Cornerstone Wealth Management's NUVB Position: Q2 2026 in Review

Cornerstone Wealth Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 11,342 shares worth $64.4K. The position accounts for ﹤0.01% of the portfolio, ranked #734.

Cornerstone Wealth Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $100K in Q4 2025. 40 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Cornerstone Wealth Management held 11,342 shares of Nuvation Bio worth $64.4K as of Q2 2026.
  • Cornerstone Wealth Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of Cornerstone Wealth Management's portfolio in Q2 2026, its #734 holding.
  • Cornerstone Wealth Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • Cornerstone Wealth Management's Nuvation Bio position peaked at $100K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Cornerstone Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.